Does the Use of mTOR Inhibitors Increase Long-Term Mortality in Kidney Recipients?-Reference-Cited by-同舟云学术

Does the Use of mTOR Inhibitors Increase Long-Term Mortality in Kidney Recipients?

Published:2011-11-04 Issue:2 Volume:12 Page:277-278
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Bunnapradist S.,Kalantar-Zadeh K.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03829.x/fullpdf

Reference4 articles.

1. Design and analysis of clinical trials in transplantation: Principles and pitfalls;Schold;Am J Transplant,2008

2. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin;Cortazar;Am J Transplant,2011

3. Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the postconcept study;Lebranchu;Am J Transplant,2011

4. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial;Alberu;Transplantation,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy;Brazilian Journal of Nephrology;2020-09

2. Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study;Transplantation;2019-09

3. Management of mineral and bone disorder after kidney transplantation;Current Opinion in Nephrology and Hypertension;2012-07